Pietropaolo, Massimo <br/><br/>
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.  [electronic resource] 

 -  Pediatric diabetes  Dec 2005 
 - 184-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-543X 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-543X.2005.00127.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Autoantibodies--blood<br/>Biomarkers--blood<br/>Child<br/>Child, Preschool<br/>Diabetes Mellitus, Type 1--epidemiology<br/>Disease Progression<br/>Family<br/>Female<br/>Glutamate Decarboxylase--immunology<br/>Humans<br/>Infant<br/>Islets of Langerhans--immunology<br/>Isoenzymes--immunology<br/>Longitudinal Studies<br/>Male<br/>Prevalence<br/>Rats<br/>Risk Assessment